Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues
- PMID: 2160235
- PMCID: PMC1131354
- DOI: 10.1042/bj2670703
Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues
Abstract
1. The cyclic AMP-dependent protein kinase activity-ratio assay was investigated by comparing histone and a synthetic peptide, malantide [Malencik & Anderson (1983) Anal. Biochem. 132, 32-40], as substrates. 2. In several tissues the activity ratio was higher when assayed with histone as the substrate; this result was obtained in control tissues and also in those incubated with agents known to increase cyclic AMP. The effect of these agents to increase the activity ratio was more clearly demonstrated with malantide. 3. The higher activity ratios observed with histone are due to: (a) measurement of phosphorylation not catalysed by cyclic AMP-dependent protein kinase; (b) activation of cyclic AMP-dependent protein kinase by histone during the assay. 4. When tissues were homogenized in buffers without NACl, lower activity ratios were found, owing to the catalytic subunit being artifactually removed from the supernatant. 5. We conclude that the measured activity ratio more faithfully reflects that in the tissue when NaCl is included in the homogenization buffer and malantide is used in the assay. This was confirmed in experiments where cyclic AMP-dependent protein kinase was added to the tissue before homogenization, and no dissociation of the exogenous enzyme was observed.
Similar articles
-
Evaluation of kemptide, a synthetic serine-containing heptapeptide, as a phosphate acceptor for the estimation of cyclic AMP-dependent protein kinase activity in respiratory tissues.Biochem Pharmacol. 1990 Jan 15;39(2):271-83. doi: 10.1016/0006-2952(90)90026-h. Biochem Pharmacol. 1990. PMID: 2154228
-
Synthetic substrate for cyclic AMP-dependent protein kinase.Nature. 1975 Oct 2;257(5525):416-8. doi: 10.1038/257416a0. Nature. 1975. PMID: 170533 No abstract available.
-
Ovarian adenosine 3':5'-cyclic monophosphate-dependent protein kinase(s). Regulation by choriogonadotropin and lutropin in rat ovarian cells.Biochem J. 1976 Aug 15;158(2):175-82. doi: 10.1042/bj1580175. Biochem J. 1976. PMID: 186032 Free PMC article.
-
Determination of soluble cAMP-dependent protein kinase activity in guinea-pig tracheal smooth muscle. Preferential use of kemptide as a phosphorylating substrate.Biochem Pharmacol. 1990 Apr 15;39(8):1365-74. doi: 10.1016/0006-2952(90)90014-c. Biochem Pharmacol. 1990. PMID: 2322318
-
Differential responses of cyclic GMP-dependent and cyclic AMP-dependent protein kinases to synthetic peptide inhibitors.Biochem J. 1983 Jul 1;213(1):159-64. doi: 10.1042/bj2130159. Biochem J. 1983. PMID: 6615418 Free PMC article.
Cited by
-
A 5-hydroxytryptamine receptor in human atrium.Br J Pharmacol. 1990 Aug;100(4):879-85. doi: 10.1111/j.1476-5381.1990.tb14108.x. Br J Pharmacol. 1990. PMID: 2169944 Free PMC article.
-
In-vivo phosphorylation of the cardiac L-type calcium channel beta-subunit in response to catecholamines.Mol Cell Biochem. 1996 Oct-Nov;163-164:99-106. doi: 10.1007/BF00408645. Mol Cell Biochem. 1996. PMID: 8974044
-
A 5-HT4-like receptor in human right atrium.Naunyn Schmiedebergs Arch Pharmacol. 1991 Aug;344(2):150-9. doi: 10.1007/BF00167212. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1658664
-
The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.Br J Pharmacol. 1992 Oct;107(2):463-70. doi: 10.1111/j.1476-5381.1992.tb12768.x. Br J Pharmacol. 1992. PMID: 1422592 Free PMC article.
-
Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage.J Alzheimers Dis. 2009;17(3):531-9. doi: 10.3233/JAD-2009-1069. J Alzheimers Dis. 2009. PMID: 19363259 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources